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Deep Venomics Reveals the Mechanism for
Expanded Peptide Diversity in Cone Snail
Venom*□S
Se´bastien Dutertre‡¶, Ai-hua Jin‡¶, Quentin Kaas‡, Alun Jones‡, Paul F. Alewood‡,
and Richard J. Lewis‡§
Cone snails produce highly complex venom comprising
mostly small biologically active peptides known as cono-
toxins or conopeptides. Early estimates that suggested
50–200 venom peptides are produced per species have
been recently increased at least 10-fold using advanced
mass spectrometry. To uncover the mechanism(s) re-
sponsible for generating this impressive diversity, we
used an integrated approach combining second-genera-
tion transcriptome sequencing with high sensitivity pro-
teomics. From the venom gland transcriptome of Conus
marmoreus, a total of 105 conopeptide precursor se-
quences from 13 gene superfamilies were identified.
Over 60% of these precursors belonged to the three
gene superfamilies O1, T, and M, consistent with their
high levels of expression, which suggests these cono-
toxins play an important role in prey capture and/or
defense. Seven gene superfamilies not previously iden-
tified in C. marmoreus, including five novel superfami-
lies, were also discovered. To confirm the expression of
toxins identified at the transcript level, the injected
venom of C. marmoreus was comprehensively analyzed
by mass spectrometry, revealing 2710 and 3172 pep-
tides using MALDI and ESI-MS, respectively, and 6254
peptides using an ESI-MS TripleTOF 5600 instrument. All
conopeptides derived from transcriptomic sequences
could be matched to masses obtained on the TripleTOF
within 100 ppm accuracy, with 66 (63%) providing
MS/MS coverage that unambiguously confirmed these
matches. Comprehensive integration of transcriptomic
and proteomic data revealed for the first time that the
vast majority of the conopeptide diversity arises from a
more limited set of genes through a process of variable
peptide processing, which generates conopeptides with
alternative cleavage sites, heterogeneous post-transla-
tional modifications, and highly variable N- and C-termi-
nal truncations. Variable peptide processing is expected
to contribute to the evolution of venoms, and explains
how a limited set of  100 gene transcripts can generate
thousands of conopeptides in a single species of cone
snail. Molecular & Cellular Proteomics 12: 10.1074/
mcp.M112.021469, 312–329, 2013.
Cone snails are slow-moving predatory marine gastropods
that hunt a variety of preys including fish (1) using venom
optimized through more than 33 million years of evolution (2).
The success of this strategy relies on the deployment of
potent toxins targeted to the nervous system and musculature
of the prey using a specialized radula tooth (3). This hollow
harpoon-like structure delivers venom deep into the prey’s
flesh, where it can enter the circulatory system and interact
with nerves to induce rapid paralysis (4, 5). It is not surprising
that human envenomations resulting from certain cone snail
stings are potentially lethal (e.g. the fish hunting Conus
geographus), given the conservation of neurological and neu-
romuscular receptors in vertebrates (6). What first appeared
as an unfortunate coincidence is now emerging as a promis-
ing source of novel drugs to treat a wide range of human
diseases (7). Indeed, cone snail venoms are now regarded as
pharmacological treasures, and significant research efforts
are being made to uncover the therapeutic potential of these
molecules (8). One such molecule, the N-type channel selec-
tive blocker -conotoxin MVIIA, is now an FDA-approved
drug to treat unmanageable chronic pain (9), and an optimized
version of the norepinephrine transporter inhibitor -cono-
toxin MrIA (Xen2174) is in Phase IIa trials for cancer and
post-surgical pain (10). In addition, several other cone snail
compounds are being investigated for the treatment of neu-
ropathic pain, epilepsy, cardiac infarction, and neurological
diseases (11).
The majority of molecules found in cone snail venoms are
small, bioactive, and heavily post-translationally modified
peptides collectively known as conopeptides (12). The disul-
fide-rich peptides ( 2 disulfide bonds) are called conotoxins
and represent the majority of conopeptides. Traditional bio-
chemical methods to isolate and sequence these potential
bioactives are time consuming and often sample limited.
Presently, it is estimated that  2% of the total conopeptide
diversity has been sequenced (13). Conopeptides are synthe-
sized in the venom gland as precursor proteins from a single
gene comprising highly conserved signal peptide, propeptide
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region, and hypervariable toxin sequence (14), and classified
into gene superfamilies according to the sequence similarities
of their signal peptide in the precursor. The use of signal
peptide-specific primers to amplify isoforms from known gene
superfamilies accelerated discovery. However, this relatively
straightforward strategy can only be used to increase our
knowledge of already identified gene superfamilies and is
unable to discover new ones. Additionally, the characteriza-
tion of conopeptide gene products require other techniques,
such as mass spectrometry, because of the numerous and
highly diverse post-translational modifications (PTMs)1 ob-
served in mature conopeptides, which cannot easily be pre-
dicted from precursor sequences. Over the past three-de-
cades,  1400 conopeptide sequences have been isolated
from 92 different cone snail species, with as few as 210
peptides being validated at the protein level. Therefore, while
we appreciate the enormous diversity present in the venom of
this genera and have extensive knowledge on conopeptides
in general (11), there is no comprehensive study on the set of
toxins produced in the venom gland even of a single species.
Cone snail venoms are highly complex mixtures, with early
estimates ranging from 50 to 200 conopeptides per species.
However, recent reports showed the presence of  1000
different peptides in a single venom using optimized liquid
chromatography LC-MS approaches (15, 16). Surprisingly,
venom gland transcriptomes of several species have revealed
a much more limited number of conopeptide genes ( 100)
(17–19). This large discrepancy between the number of genes
and the number of masses detected in the venom is currently
not well understood. Differential PTM processing can only
partially explain the observed venom complexity, since most
conopeptides have on average only two modified positions
(excluding disulfide bond formation) that would generate up to
400 peptides from 100 genes. To better understand the
mechanisms responsible for cone snail venom peptide diver-
sity, we have integrated transcriptomic and proteomic ap-
proaches using bioinformatics in a strategy coined “deep
venomics” (20), to fully explore the origin(s) of the thousands
of conopeptides found in the venom of Conus marmoreus.
This well-studied mollusc-hunting cone snail produces po-
tent analgesic compounds, including -conotoxin MrIA (10,
21) and O-conotoxin MrVIB along with 40 other identified
conotoxins.
From the different second-generation sequencing plat-
forms, the 454 pyrosequencing technology was selected as it
generates relatively long reads (on average 300 bp) that can
cover the full length of conopeptide precursors (70–100
amino acid). This approach allows direct identification of
conopeptide precursors, avoiding the errors inherent to the
assembly of reads into contigs typically required for other
second-generation technologies that generate shorter read
lengths (22). To complement this approach, we performed a
detailed proteomic investigation using three high sensitivity
mass spectrometers and developed dedicated bioinformatic
tools for data integration. Besides the identification of 72
novel conopeptide precursors and five novel gene superfami-
lies, this study revealed for the first time extensive and highly
variable processing of the N- and C termini and PTMs that
dramatically increased venom peptide diversity. This variable
peptide processing, together with intra-species variation, ex-
plains how a limited set of  100 gene transcripts can gen-
erate thousands of conopeptides in the venom of a single
species of cone snail.
EXPERIMENTAL PROCEDURES
RNA Extraction, cDNA Library, 454 Sequencing and Assembly—
One single adult specimen of C. marmoreus collected from the Great
Barrier Reef (Queensland, Australia) and measuring 6 cm was dis-
sected on ice. The venom duct was removed and directly placed in a
1.5 ml tube with 1 ml of TRIZOL reagent (Invitrogen, Carlsbad, CA).
The extraction of total RNA was carried out following the manufac-
turer’s instructions. We obtained 44.8 g of total RNA, which was
further purified using Oligotex mRNA Mini Kit (Qiagen, Valencia, CA),
yielding  400 ng of mRNA. From this sample, 200 ng was submitted
to the AGRF (Australian Genomic Research Facility) for cDNA library
construction and sequencing. Preparation of the cDNA library con-
sisted of several major steps, including fragmentation of RNA, syn-
thesis of double-stranded cDNA, fragment end repair, preparation of
AMPure beads, ligation of adaptors, removal of small fragments,
quantitation, and quality assessment of the cDNA library. Sequencing
was carried out on a Roche GS FLX Titanium sequencer. In addition
to our sample, three other samples from a related project were run
together on a full plate, using a unique barcode for each sample. After
sorting, cleaning and trimming of the reads, sequence assembly
(contigs) was carried out using Newbler 2.3 (Life Science, Frederick,
CO).
Conopeptide Sequence Analysis—Raw reads and contigs were
up-loaded in a proprietary web-based searchable database. The
identification of conopeptide sequences was carried out from the raw
data using tBlastn and either signal sequences or mature sequences
retrieved from the ConoServer (23). As mentioned previously, such
long sequence reads are likely to contain the full nucleic sequences of
conopeptide precursors. The identified conopeptide sequences were
then aligned using Multalin program (24). At this stage, redundant
sequences, incomplete precursor sequences and aberrant se-
quences (i.e. extended N-terminal due to frameshifts or degenerate
positions) were removed. Alignments were then edited with Jalview
and the sequence clustering tree was constructed from “average
distance using % identity” algorithm implemented in the Jalview
program (25). Gene superfamilies, signal peptides, and cleavage sites
were predicted using the ConoPrec tool implemented in ConoServer
(26). The cutoff value for assigning a signal peptide to a gene super-
family was set at  75% sequence identity, as extrapolated from a
recent analysis of all precursors deposited in ConoServer (13).
Venom Sample Preparation—Six adult ( 6 cm) specimens of C.
marmoreus were collected from the Great Barrier Reef (Queensland,
Australia) and held in aquaria for several months. Temperature was
maintained between 24–28 °C and a light cycle of 12:12 was applied.
Milking of all snails was carried out once a fortnight. The procedure
involved enticing the cone snails with live prey (gastropod mollusks)
to initiate extension of the proboscis. Then, a 0.5 ml collecting tube
comprising a fine slice of the prey’s foot tissue stretched over the
1 The abbreviations used are: PTM, post-translational modification;
MALDI, Matrix-assisted laser desorption ionization; ESI, electrospray
ionization.
Venomics of Conus marmoreus
Molecular & Cellular Proteomics 12.2 313
opening sealed with parafilm was presented to the snail. On repeated
contact of the proboscis with the piece of foot tissue, at times with
agitation, a radula was eventually fired and venom ejected into the
tube. After each collection, the pooled injected venom was stored
immediately at 20 °C until further use (total from 25 milkings was
 200 l). This batch of venom has been used for all subsequent MS
experiments.
HPLC Fractionation for MALDI—100 l supernatant of the pooled
injected venom was fractionated using a Thermo C18 4.6  150 mm
column fitted to a Shimadzu Prominence HPLC system with 0.043%
trifluoroacetic acid/90% acetonitrile (aq) as elution buffer B and
0.05% trifluoroacetic acid (aq) as buffer A. A linear 1% B min1
gradient was delivered to the column at a flow rate of 1 ml min1 over
80 min. The eluent was monitored using a dual wavelength UV de-
tector set to 214 and 280 nm and fractions collected from the 214 nm
trace.
Reduction-Alkylation—The buffer used for reduction and alkylation
was 30% acetonitrile/100 mM NH4HCO3 at pH 8. Tris(2-carboxyethyl)-
phosphine (TCEP) was used as the reducing reagent and maleimide
was used as the alkylating reagent. All samples including the raw
injected venom (10 l supernatant) and the fractionated venom (2/3 of
the fractions) were lyophilized and reconstituted in 50 l of the above
buffer prior to the reduction and alkylation procedure. The sample
solution was incubated with 10 l of 100 mM TCEP at 60 °C for 1 h
under nitrogen. Alkylation was carried out on the reduced raw injected
venom by addition of 10 l of 100 mM maleimide and the reaction
mixture was incubated for 1 h before LC purification.
Matrix-assisted Laser Desorption Ionization-MS—Matrix-assisted
laser desorption ionization (MALDI)-MS analyses were conducted
using an AB SCIEX (Framingham, MA, USA) 4700 TOF-TOF Proteom-
ics Analyzer. The fractionated venom samples (1/3 of each fraction)
were reconstituted in 5 l 50% acetonitrile/0.1% formic acid (aq) and
0.5 l of the samples were deposited on a 192-well stainless steel
plate through 1:1 dilution with matrix consisting 10 mg ml1 -cyano-
4-hydroxycinnamic acid (CHCA) in 50% acetonitrile/0.1% formic acid
(aq). For LC-MALDI analysis, 10 g of the injected venoms (native)
were diluted in 22 l 0.1% formic acid (aq). Of this solution, 20 l was
analyzed using a Vydac Everest® C18 (300 m  150 mm) capillary
LC column on the Agilent nano 1100 series HPLC system. During
fractionation, a CHCA solution (10 mg ml1 in 50% acetonitrile/50%
ethanol) was added 1:1 to the effluent and samples were deposited
on a 192-well stainless steel plate using a plate spotter. MALDI-TOF
spectra were acquired in reflector positive operating mode with
source voltage set to 20 kV and Grid1 voltage at 12 kV, mass range
1000–8000 Da, focus mass 3500 Da. The plate was calibrated using
Calmix (4700 Proteomics analyzer calibration mixture) from Applied
Biosystems (Foster City, CA).
LC-electrospray Ionization (ESI)-MS and LC-ESI-MS/MS—Liquid
chromatography and electrospray mass spectrometry were per-
formed on two advanced AB SCIEX instruments (Framingham, MA,
USA). The AB Sciex QSTAR Pulsar is an electrospray quadruple
time-of-flight (QqTOF) MS equipped with a Turbo-Spray ionization
source and coupled to an upstream Agilent 1100 series HPLC sys-
tem. In contrast, the AB Sciex TripleTOF 5600 System is a hybrid
quadruple TOF MS equipped with a DuoSpray ionization source
coupled to a Shimadzu 30 series HPLC system. For comparison, the
same amount of raw injected venom ( 8 l supernatant) was directly
subjected to LC-ESI-MS to obtain a complete mass list of underiva-
tized peptides. Full scan mass spectrometric analysis and product ion
MS/MS analysis using Information Dependent Acquisition (IDA) ex-
periments were performed using the 5600 TF on the reduced and
reduced/alkylated injected venom samples. The LC separation was
achieved using a Thermo C18 4.6  150 mm column at a linear 1.3%
B (90% acetonitrile/0.1% formic acid (aq)) min1 gradient with a flow
rate of 0.3 ml min1 over 60 min. A cycle of one full scan of the mass
range (MS) (300–2000 m/z) followed by multiple tandem mass spectra
(MS/MS) was applied using a rolling collision energy relative to the
m/z and charge state of the precursor ion up to a maximum of 80 eV.
The full scan mass spectrometry had duration of 84 min with a cycle
time of 2.55 s (total of 1975 cycles). The maximum number of candi-
date ions monitored per cycle was 20 and the ion tolerance was 0.1
Da. The switch criteria were set to exclude former target ions for 8 s
and to exclude isotopes within 4 Da.
Bioinformatic Tools—Raw data extracted from mass spectrometry
instruments often contain replicates and deconvolution artifacts (e.g.
assignment of two monoisotopic masses for the same molecule
during the automatic reconstruction step) that need to be cleaned
before use for further analysis. To this end, two useful tools have been
implemented to help our analyses, and these tools (“Remove dupli-
cate masses” and “Compare mass lists”) have been made publicly
available on the ConoServer website. The first tool removes dupli-
cates in a list of masses using a user-defined mass precision param-
eter, whereas the second tool identifies common masses between
two mass lists. Correctly assigning a mass to a conotoxin predicted
from a precursor protein is challenging because conopeptides are
heavily post-translationally modified. To date, 14 different types of
post-translational modifications (PTMs) have been identified in ma-
ture cone snail toxins (13). The problem of identifying a conopeptide
from a gene sequence is increased by the presence of differential
post-translational processing. ConoMass was implemented in Cono-
Server to help in the identification of conotoxins by mass spectrom-
etry (26). In this two-step process, monoisotopic and average masses
resulting from variable PTM processing are computed for each pep-
tide and then matched to masses observed experimentally without
relative mass accuracy correction. These bioinformatic tools are im-
plemented in PHP, Python, and Mysql and are available online at the
ConoServer website (http://www.conoserver.org) (26).
Proteomic Data Analysis—LC-ESI-MS reconstruction was carried
out using Analyst LCMS reconstruct BioTools (Framingham, MA,
USA). The mass range was set between 1000–8000 Da. Molecules 
8000 Da were observed but excluded from further analysis. The mass
tolerance was set to 0.2 Da and S/N threshold was set to 10. The MS
data matching was carried out using the ConoMass tools (see below)
followed by critical manual inspection. The precision level was set to
0.1 Da for automatic matching search. Manual search accuracy was
set to 100 ppm. Deconvoluted mass lists from different instruments
were cross-calibrated, compared, cleaned and binned using two
bioinformatic tools, namely “Compare mass lists” and “Remove du-
plicated masses,” which are available on the ConoServer website.
The precision level used for binning and comparing masses was set
to 0.2 Da. The ProteinPilot™ 4.0 software (AB SCIEX, Framingham,
MA, USA) was used for sequence identification by searching the
LC-ESI-MS/MS mass lists obtained at a mass tolerance of 0.05 Da for
precursor ions using the reduced and reduced/alkylated samples.
These masses, and related fragmentation masses (0.1 Da tolerance),
were matched against a protein database comprising all ConoServer
conopeptides, NCBI cone snail related proteins and all read se-
quences obtained from this transcriptomic project (2,157,997 entries).
Modifications used in the search include the following: amidation,
deamidation, hydroxylation of proline and valine (27), oxidation of
methionine, carboxylation of glutamic acid, cyclization of N-terminal
glutamine (pyroglutamate), bromination of tryptophan (28), and sulfa-
tion of tyrosine (29). The O-glycosylation PTMs were not included in
our search as this modification has not been reported for C. mar-
moreus conopeptides (glycosylation occurs infrequently and mostly
in fish-hunting species) and the typical fragment loss associated with
glycosylation was not seen by MS in this venom. The threshold “Conf”
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value for accepting identified spectra was set to 99. Identified peptide
sequences were inspected manually to confirm assignment.
RESULTS
Transcriptomic Data Analysis—A single run (1⁄4-plate equiv-
alent) on the Roche GS FLX Titanium sequencer generated
179,843 reads averaging 317 bp (min 18 bp) in length after
removal of low-quality sequences. 114,159 reads were as-
sembled into 839 contigs, and the rest remained as single-
tons. Although this study focused mainly on conopeptides,
many protein and enzyme sequences were also identified
among the contigs and will be described elsewhere. As out-
lined in the experimental procedures section, we searched for
conopeptide sequences directly from the sequencing reads,
as the average read length of  300 bp allowed full conopep-
tide precursors to be found. Conopeptides were also
searched in the contigs, and no additional conopeptide se-
quences were found. Overall, 105 unique conopeptide se-
quences were retrieved from the venom duct transcriptome of
C. marmoreus. The conopeptide precursors were named
Mr001 to Mr105 and are shown in Fig. 1. From the 42 previ-
ously known conopeptide sequences from C. marmoreus, 30
were identified in our data (28.5% of total precursors recov-
ered; Table I) along with 75 new sequences. The conopeptide
precursor sequences were clustered into 13 gene superfami-
lies (Figs. 1 and 2) confirmed using the ConoPrec tool in
ConoServer. Superfamilies previously identified in C. mar-
moreus include the A, I2, M, O1, O2, and T. The disulfide poor
conopeptides contryphans and conomarphins were classified
in the gene superfamilies O2 and M, respectively, as recently
suggested (30, 31) (Fig. 1 and Supplemental Fig. S1). In ad-
dition to these superfamilies, we also found sequences be-
longing to superfamilies I1 and S that had not previously been
reported for C. marmoreus. Finally, from the remaining 13
unclassified conopeptide precursors, five groups could
clearly be identified, based on their signal peptide sequence
similarity and named gene superfamilies B, H, N, E, and F. As
detailed below, conopeptides belonging to gene superfamily
N and H show typical mature conotoxins, while gene super-
family B, E, and F are represented by only one sequence and
appear to be also quite divergent.
Some conopeptide precursors were markedly more abun-
dant than others. Indeed, the three most expressed conopep-
tide precursors contribute 28% of the total conopeptide
reads, the next 20 contribute to 46.5% of the reads, whereas
the remaining precursors contribute only 25.5% of the reads
(Fig. 3A). This finding parallels that of Conticello et al., where
order-of-magnitude differences were observed in the expres-
sion levels of individual conopeptides in five Conus species,
with a few transcripts typically dominating the sequenced
clones in a given species (32). Not surprisingly, nearly all
peptides with a corresponding number of reads above 300
were already either characterized from the venom or discov-
ered from cDNA clone libraries, with the exception of two
conopeptide precursor, Mr047 and Mr096 (Fig. 3B). This ob-
servation suggests that the toxins most expressed at the
mRNA level tend also to be the more abundant in the venom
and thus are usually biochemically characterized first. A linear
regression (r2  0.88) indicated that gene superfamilies with
the largest number of precursors also had the highest number
of total reads (Fig. 3C). Only gene superfamily I2 was an outlier
to this regression, with a relatively high number of precursors
(10) but low expression levels. Overall, gene superfamily M
has the highest number of reads and the largest number of
precursors. A large proportion of the reads assigned to gene
superfamily M match to precursor Mr044, which encodes
conopeptide Mr3.8 (two sequences, Mr3.8 and MrIA, have 
1000 reads). It is interesting to note that this conopeptide is
the most highly expressed in the venom gland, yet its phar-
macology remains unknown.
The Injected Venom of C. marmoreus—To study the venom
most relevant to prey capture and defense (containing fully
mature peptides), we adapted the milking method described
by Hopkins et al. to collect the injected venom of a mollusk-
hunting cone snails for the first time (Fig. 4A) (33). This method
allowed several C. marmoreus specimens to be milked for a
comprehensive proteomic study. C. marmoreus has relatively
short radula ( 2.5 mm) making this species challenging to
“milk.” The injected venom of C. marmoreus has a milky
appearance (Fig. 4B), in contrast to the translucent venom
obtained from “hook-and-line” piscivorous species. The milky
appeareance is mainly due to the presence of secretory gran-
ules (Fig. 4C) that appear similar to those found in the venom
duct of another molluscivorous cone snail, C. victoriae (34).
The volume of the injected venom seems to vary according to
the size of the animal, and generally 10–20 l were collected
per milking, with six different individuals pooled for our pro-
teomic analysis.
Mass Spectrometry—We used ESI or MALDI sources in
LC-ESI-MS (QSTAR Pulsar), MALDI-MS (4700 TOF-TOF Pro-
teomics Analyzer) and LC-ESI-MS/MS (TripleTOF 5600 Sys-
tem) configurations to uncover the complexity of C. mar-
moreus injected venom. Using a precision of  0.2 Da for
binning the mass list, single 115 min LC-ESI-MS run on the
QSTAR instrument revealed 3172 unique masses (from the
6867 raw data mass list) in the milked venom of C. marmoreus
(Fig. 5B). An exhaustive MALDI analysis, including both 33
min LC-MALDI run (192 spots) and manually spotted UV-
absorbing fractions from a HPLC run, identified a comparable
number of masses (2710). However, only 1219 (45%) masses
were common between the QSTAR and the 4700 MALDI
instruments indicating significant detection bias. In compari-
son, 6254 unique masses (from the 15757 total masses de-
tected) were identified using the TripleTOF 5600 from a single
LC-ESI-MS run (TIC trace shown in Fig. 6), of which 2448
overlapped with the QSTAR (77%) and 1776 overlapped with
the MALDI (65%). Overall, 1105 common masses could be
identified from all three instruments with a precision of 0.2 Da
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FIG. 1. Alignment of C. marmoreus conotoxin precursors retrieved from next generation sequencing data. Sequences have been
clustered by gene superfamily, according to their signal peptide. Gaps have been introduced to optimize the alignment sequence identity. Color
coding has been applied using the following scheme: cysteine residues are in yellow, negatively charged residues are in red, positively charged
residues are in blue, polar uncharged residues are in green, methionine residues are in orange and hydrophobic residues are in white.
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(Fig. 5B) from a total of 7798 unique masses detected across
the three instruments. Although this number is the largest
reported for any venom, our stringent conditions for sorting
the mass list from the raw data likely under-estimate the total
number of peptides present, since peptides with similar
masses but distinct retention times would not be counted. In
addition, with a threshold S/N conservatively set to 10, some
minor components were also missed (Supplemental Fig. S2).
Furthermore, only 32 possible Na-adducts, 37 possible K-
adducts, and 26 possible Fe-adducts were identified in the
MALDI mass list of (3.5% of 2710 masses). In the 5600 TF
mass list, 338 possible adduct products were found from
6254 masses (5.4%), however,  50% of these masses had
distinct retention times, indicating most were in fact different
peptides and not salt adducts. Deconvolution artifacts were
also considered, and isotopic masses envelopes (1 to 8)
with the same retention time were removed, along with pos-
sible loosely associated masses within 0.5 Da that had the
same retention time. Finally, in-source fragments were also
been considered, however, the mild conditions used for TOF
FIG. 2. Sequence identity within and between gene superfami-
lies signal peptide sequences. The minimum percentage of se-
quence identities computed between signal peptide sequences of
precursor belonging to the same gene superfamily are on a black
background. The maximum percentage identities measured between
signal peptide sequences of precursors belonging to different gene
superfamilies are on a white or gray background. Comparisons be-
tween the new gene superfamilies and the previously known gene
superfamilies are highlighted on a gray background. The percentage
of sequence identities were computed for all pairs of sequences using
a Smith and Waterman algorithm, and the percentage of identity was
computed using the length of the smallest sequence. The gene su-
perfamily M was detailed into three branches: m-1, m-2 and m-c
(conomarphins).
FIG. 3. Levels of mRNA expression of individual conotoxins and
conotoxin superfamilies in the venom duct of C. marmoreus. A,
The total number of reads is plotted per precursor, demonstrating the
efficacy of the sequencing effort. B, Dramatic variations in the level of
expression were noted for individual conotoxin. Interestingly, most
conotoxin with a number of reads above 300 were already discovered
either from the venom or using PCR amplification strategies. C, The
number of isoforms and the total number of reads per gene super-
family show an apparent correlation. The goodness of fit was R2 
0.88, revealing a significant correlation between the two parameters.
Venomics of Conus marmoreus
318 Molecular & Cellular Proteomics 12.2
scan (ESI) were expected to produce few in-source frag-
ments. For the MALDI experiments, only mild MS-RP acqui-
sition on CHCA matrix were performed, preventing in-source
fragmentation.
It is surprising that only 77% of the Qstar masses over-
lapped with those of the 5600 TF within 0.2 Da precision
range, while both instruments use the same ionisation
method. It is likely that the accuracy of the measurement
between the two instruments accounts for this discrepancy.
For example, the reconstructed mass of MrVIB (Mr051, MW
3403.58 Da) from the two instruments showed that the 5600
TF produces highly accurate data (within 0.01 Da of the the-
oretical mass), while the Qstar was less reliable (mass differ-
ence of 0.26 Da). Increasing our precision to 0.5 Da signifi-
cantly improved overlap to 87%, confirming that instrument
accuracy was a major contributor to the incomplete overlap
observed between the Qstar and 5600 TF detected masses.
The mass distribution of the injected venom of C. marmoreus
inferred from each instrument is shown in Fig. 5A. As ex-
pected, small peptides dominated the venom, especially
those in the range 1000–2000 Da, while similar numbers of
peptides were detected for the ranges 2000–3000 Da and
3000–4000 Da. Proteins larger than 8 kDa were also de-
tected, however, they represent relatively minor components
of C. marmoreus injected venom and were not analyzed fur-
ther in this study.
Matching Transcriptomic and Proteomic Data Using Dedi-
cated Bioinformatic Tools—Calculated masses from all 102
predicted mature sequences were compared with masses
identified using the three instruments (Supplemental Table S1;
precursors Mr069, Mr070, and Mr071 that only contained a
proregion were excluded from this analysis). The TripleTOF
5600 System detected all 102 mature sequences within 100
ppm. In contrast, the QSTAR data could be matched to 79
(77%) of the mature conopeptides, including 69 within 100
ppm and 26 were not detected, while MALDI data could be
matched to 71 (67%) of the mature peptides, including 69
within the 100 ppm and 34 not detected. As expected, the
precision match (smaller delta mass) was higher for short
sequences ( 20–25 amino acids), in part because longer
sequences have proportionally more possible PTMs. A single
mass may correspond to several possible peptides, but de-
tailed MS/MS data and knowledge of each gene superfamily
PTM profile allowed discrimination of the different possible
solutions. Below we describe the conopeptides identified,
FIG. 4. Milking of the molluscivorous cone snail C. marmoreus.
A, A prey (left) is placed at the front end of a C. marmoreus specimen
to induce extension of the proboscis. A centrifuge tube covered with
parafilm and piece of external tissue from the foot of the prey is then
presented at the tip of the extended proboscis. On contact, a radula
is usually fired and venom injected into the collecting tube. A quick
centrifugation is then carried out to pellet the droplets of venom to the
bottom of the tube before storage at –20 ° C. B, Pool of crude injected
venom from several specimens of C. marmoreus. C, The white color
of the injected venom appears to be due to the presence of  25–30
m long oval-shaped granules, as seen under an optical microscope
(40).
FIG. 5. Distribution of the masses detected in the injected
venom of C. marmoreus by three different MS instruments. A,
Histograms represent the number of masses detected per instru-
ments and per mass range. While QSTAR ESI and 4700 MALDI show
a similar pattern of distribution, the highly sensitive TripleTOF 5600
System instrument detected significantly more molecules. B, This
diagram illustrates the complementarity of our approach, as only 1105
masses were common between all instruments using a stringent 0.2
Da matching criteria.
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their gene superfamily, precursor cleavage sites, and MS/MS
coverage.
Gene Superfamily A—Only two precursors from gene su-
perfamily A were identified in our transcriptomic data. From
the three previously known -conotoxins, only Mr1.1 could be
found in our transcriptome data (Mr001), and Mr1.2 and Mr1.3
were absent. The molecular targets of these small peptides
are the various subtypes of nicotinic acetylcholine receptors,
although recent findings indicate that GABAB is also a poten-
tial pharmacological target (35). Mr1.1 was recently found to
be analgesic in an animal model of inflammatory pain (36). In
our data set we found a novel -conotoxin isoform, Mr002,
which has high similarity to Bn1.2, a peptide isolated from the
closely related C. bandanus. The proregions of Mr001 and
Mr002 are different and contain the presequence cleavage
sites LTVK and LNAR, respectively, which were confirmed by
MS/MS sequencing. Both Mr001 and Mr002 have similar
levels of expression, with 35 and 20 reads, respectively.
MS/MS data of Mr1.1 (Mr001) indicated that the mature form
has an amidated C terminus. This is the first time that Mr1.1
has been identified at the peptide level. In contrast, mature
Mr002 peptide had two hydroxyprolines and a serine instead
of the C-terminal glycine found in its precursor.
Gene Superfamily I1—Three gene superfamily I1 precursors
were detected in our transcriptome data, and all three showed
relatively low levels of expression. Fourteen reads were found
coding for Mr004, but only three for Mr005 and one for Mr003.
The presequence cleavage site in these precursors is LR,
producing 40–45 amino acid long mature peptides with four
disulfide bonds that were confirmed by MS/MS. Most cono-
peptides from the gene superfamily I1 isolated to-date pro-
duce general excitatory symptoms in mice, possibly through
effects on sodium channels (37).
Gene Superfamily O2—Ten precursors belonging to the
gene superfamily O2 were sequenced and further classified
into three subgroups based on signal peptide sequence sim-
ilarities (Figs. 1 and Supplemental Fig. S1). Five precursors in
the first subgroup coded for mature peptides of 24–27 amino
acids and three disulfide bonds (Mr006-Mr010). Only one
peptide in this gene superfamily, produced by precursor
Mr007, was already known from C. marmoreus (Mal51), and
this precursor was represented by 10-times more reads than
the other members of this subgroup (38). Each of these ten
precursors contained the presequence cleavage site KR, gen-
erating mature peptides for Mr006, Mr007, and Mr008 with a
predicted N-terminal pyroglutamate and amidated C terminus
(except Mr010). Mal51 and the mature sequences of Mr009
and Mr010 were confirmed by MS/MS. Although MS/MS ev-
idence for the predicted pyroglutamate and C-terminal ami-
dation was found for the abundant Mal51, the unmodified
mature peptide unexpectedly dominated in the venom.
The second subgroup contained three precursors (Mr011-
Mr013), which are expressed at a low level ( 25 reads). The
signal peptide of these precursors shared 90% sequence
homology with known gene superfamily O2 precursors, but
the propeptide and predicted mature peptide regions were
different. The pre-cleavage sites (LIGR or LTGR) precede
mature peptides of 34–35 amino acids, which display an eight
residue N-terminal tail and three disulfide bonds. A conserved
lysine residue at position 48 (see Fig. 1 alignment) constitutes
a second cleavage site, resulting in mature peptides of 26–27
amino acids in length and three disulfide bonds. Indeed, these
shorter peptides were confirmed by MS/MS sequencing as
being the dominant mature products. Interestingly, MS/MS
data could be confidently matched to several isolated pro-
peptide regions excised from precursors from this subgroup.
FIG. 6. Total Ion Current trace of the
injected venom of C. marmoreus.
LC-MS run on the TripleTOF 5600 Sys-
tem revealed the complexity of the in-
jected venom of C. marmoreus. De-
tected masses corresponding to the
previously identified conotoxins have
been indicated.
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The identified propeptide region sequences are DEENLLKP-
MIYFILIGR for Mr011 and DGENPLKALIDILTGR for Mr012.
Finally, two precursors coding for contryphans were found
to cluster with the gene superfamily O2: Mr014 (contry-
phan-M) and Mr015. Contryphan-M was highly expressed
with 82 reads, whereas Mr015 was expressed at  20-fold
lower frequency. The cleavage site KVLR for Mr015 pro-
duced a ten residue mature peptide corresponding to a
truncated contryphan-M, and this peptide was confirmed by
MS/MS sequencing. In addition, the C-terminal amidation of
both contryphan-M and Mr015 mature peptides was validated
by MS/MS.
Gene Superfamily S—Only eight conopeptides from gene
superfamily S are known in the entire ConoServer database.
Two new precursors belonging to this gene superfamily were
found in our C. marmoreus transcriptome and both were
expressed at a low level ( 10 reads). Full length Mr016 has
only three cysteines, whereas other members of the super-
family S belong to cysteine framework VIII and have ten
cysteines. Conopeptides with an odd number of cysteines are
rare, but some were recently shown to form disulfide bonded
homodimers (39). However, the expected dimer (7041.55 Da)
was not detected in the venom. The second precursor had a
partially truncated signal peptide, but the predicted mature
peptide possessed the canonical cysteine framework VIII.
Both of the predicted mature peptides without PTMs were
matched to peptide masses within 100 ppm using MS, how-
ever, MS/MS data could not confirm these sequences.
Gene superfamily I2—Ten precursors were identified for the
I2 gene superfamily, yet none had level of expression higher
than 50 reads. Previously identified Gla-MrII (Mr019) was
found in our transcriptomic data, but Mr12.8 was absent (40).
In contrast to other conopeptide precursors, this gene super-
family has its propeptide region located after the mature
peptide region. In addition, several peptides in this gene su-
perfamily were shown to contain -carboxylation and a rec-
ognition site for the carboxylase enzyme (41). The identifica-
tion by MS of peptides from this gene superfamily is
challenging because the predicted mature sequences are
long and potentially heavily post-translationally modified. For
example, Gla-MrII has five -carboxylations. From the ten
precursors belonging to gene superfamily I2, three subgroups
could be identified (Fig. 1). Three precursors, Mr018, Mr019
and Mr020, had Gla-MrII-like sequences and a -carboxyla-
tion motif. MS data could be associated with all the mature
peptides of all three precursors including 4–5 -carboxyla-
tions (Supplemental Table S1). Gla-MrII and the mature Mr020
sequences were confirmed by MS/MS but their -carboxyla-
tion was not detected.
A second I2 subgroup included precursors Mr021, Mr022,
Mr023, Mr024, and Mr025 that were predicted to be slightly
shorter than Gla-MrII but with a similar -carboxylation pat-
tern. Despite having different propeptide regions, Mr022 and
Mr025 share the same predicted mature sequence. Masses
corresponding to four to five -carboxylations were identified
in the MS data but mature peptides could not be confirmed by
MS/MS data. Finally, two precursors, Mr026 and Mr027, en-
coded short mature peptides containing three and four cys-
teines, respectively. A peptide fragment LCEHPEETCLLPQ
corresponding to Mr026 and/or Mr027 was identified without
PTMs by MS/MS.
Gene Superfamily M—Twenty-three precursors belonging
to the gene superfamily M were further classified into the m-1
and m-2 subgroups, which have distinct signal peptide se-
quences (42). From the eight full-length precursors belonging
to the m-2 branch, four have mature peptides that were
reported previously: Mr3.3, MrIIIB, MrIIIG, and MrIIID (43–45).
Among this group, MrIIIG precursor has the highest expres-
sion level with 230 matching reads. The predicted mature
regions are cleaved after a DSGR or DAVR motif to generate
peptides ranging from 14 to 17 amino acids and stabilized by
three disulfide bonds. Processing of both Mr028 and Mr029
precursors generates the same mature peptide Mr3.3. Good
MS/MS coverage was obtained this subgroup. The mature
peptides of Mr030 (MrIIIB), Mr031 (MrIIIG), and Mr033 (MrIIID)
each displayed a hydroxyproline in a conserved C(XO/P)CC
motif. Additionally, MrIIID has a second hydroxyproline in the
first loop, and both MrIIID and MrIIIG have an amidated C
terminus. In contrast, Mr034 and Mr035 precursors generated
mature peptides without PTMs, as identified by MS within 100
ppm accuracy. These peptides without PTM could not be
confirmed by MS/MS (Supplemental Table S1).
Twelve precursors that belong to the m-1 branch were
identified (Mr039-Mr050), including the previously character-
ized MrIIIE, MrIIIF, Mr3.8 and Mr1e precursors (43–45). All
precursors in this branch had a pre-sequence cleavage site
LGQR or KR, yielding predicted mature peptides with 11 to 16
amino acids and three disulfide bonds, except Mr1e, which
has only four cysteines. Mr044 (Mr3.8) was the most highly
expressed precursor in the transcriptome of C. marmoreus
with 1372 reads and was readily confirmed by MS/MS. The
new precursor Mr047 is also highly expressed (415 reads) but
the other new precursors identified generated only 1–73
reads. Interestingly, MS/MS data suggest that the mature
sequences of Mr041 and Mr049 contain an odd number of
cysteines. The predicted C-terminal amidation of Mr039 was
confirmed by MS/MS, whereas the mature peptide corre-
sponding to the excitatory Mr1e (45) was confirmed to contain
no PTMs by MS/MS.
Two precursors Mr036 (conomarphin) and Mr037 cluster
with the gene superfamily M (m-c branch) (30). Both precur-
sors contain the cleavage site LKKR, producing a mature
linear peptide of 17 amino acids, and both were expressed at
relatively high levels (161 and 92 reads for Mr036 and Mr037,
respectively). Interestingly, a precursor encoding the same
conomarphin was also cloned from the worm-hunter Conus
imperialis (46). MS/MS data confirmed proline hydroxylation
and identified truncated forms as previously described (47).
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The precursor Mr038 has a gene superfamily M signal pep-
tide although the propeptide and the mature peptide regions
display little homology with other gene superfamily M precur-
sors. The predicted cleavage site (RK) and removal of the
C-terminal glycine (amidation) is expected to yield a 18 amino
acid mature peptide with two cysteines and a long N-terminal
tail more similar to the contryphans than other known gene
superfamily M conopeptides (Fig. 1). Only four reads were
found to match this sequence and reliable MS/MS coverage
could not be obtained.
Gene Superfamily O1—Twenty-three precursors belonging
to the gene superfamily O1 signal peptide sequence were
identified that clustered into three distinct subgroups (Fig. 1),
each containing the cleavage site LEKR or LNKR. The first
subgroup contained six precursors (Mr051-Mr056), including
the highly expressed Mr053 (MrVIA) and Mr051 (MrVIB) (48,
49). The new precursor Mr052 had a similar sequence to the
MrVIB precursor, and the three precursors Mr054, Mr055 and
Mr056 had an odd number of cysteines and extended C-ter-
minal sequences. The mature peptide sequence of Mr052
was confirmed using MS/MS, but those of Mr054, Mr055, or
Mr056 were not supported by MS/MS. A peptide correspond-
ing to the propeptide region sequence, DEMEDPEASKLE,
was also identified using MS/MS.
A second O1 subgroup comprised three precursors Mr057,
Mr058, and Mr059. Only Mr057, which encodes for the pre-
viously characterized Malr34, was confirmed by MS/MS. The
third subgroup included 14 precursors including Mr063
(Malr332), Malr137 (Mr068), Mr6.1 (Mr066), Mr6.3 (Mr067),
and four other precursors Mr073, Mr064, Mr065, and Mr072
with similar sequences. In addition, three precursors Mr060,
Mr061, and Mr062 had elongated sequences compared with
the other precursors in this subgroup. Finally, the three re-
maining precursors (Mr069, Mr070, and Mr071) terminate with
premature stop codon. Full MS/MS sequence coverage was
obtained for Malr332, Mr6.1, Malr137, and the two mature
peptides corresponding to Mr064 and Mr065.
Gene Superfamily T—Nineteen precursors were identified
to belong to the gene superfamily T, with two subgroups
distinguished based on the sequence similarity of the propep-
tide region. The first subgroup had 15 precursors predicted to
produce six known and nine new conopeptides. The most
common cleavage site encountered in this gene superfamily is
LNKR, generating 10–21 amino acid peptides with four cys-
teines (cysteine framework X). The six known conopeptides
are Mr5.4a (Mr074), Mr5.4b (Mr075), Gla-MrIII (Mr077), Mr5.1b
(Mr078), MrVA (Mr084), and Mr5.6 (Mr085) (40, 50), with all but
Mr5.1 confirmed by MS/MS. Mr076 is similar to Mr5.4b, and
the other new precursors had an odd number of cysteines
(Mr079, Mr081, Mr082, and Mr083) or no cysteines (Mr080,
Mr086, Mr087, and Mr088).
The second subgroup comprised four similar precursors,
including the previously characterized MrIA (Mr090), CMrVIA
(Mr091), and CMrX (Mr092) (51–53). Except for the new pre-
cursor Mr089, these precursors were highly expressed (Table
II) and the presence of a hydroxyproline was confirmed by
MS/MS.
New Gene Superfamily N—Three precursors, Mr093,
Mr094, and Mr095, displaying the typical signal peptide/pro-
peptide region/mature peptide region architecture of cono-
peptides, were identified as belonging to a new gene super-
family. Each of the three precursor had a LEKR cleavage site
that delineates a mature peptides with eight cysteines. These
cysteines are arranged along the sequence in a C-C-CC-C-
C-C-C pattern corresponding to cysteine framework XV (Sup-
plemental Table S2). Interestingly, the mature peptide of
Mr093 (45 reads) was discovered as two main fragments in
the MS/MS data (CSSGKTCGSVEOVLCCARSDCYCRLIQT
and SYWVOICVCP), indicating the presence of an alternative
cleavage site generating a major framework VI/VII peptide and
a smaller disulfide-poor conopeptide.
New Gene Superfamily B—Only one precursor, Mr096, was
identified in this new gene superfamily. Despite  55% se-
quence identity to signal peptides from other gene superfami-
lies its level of expression was high (323 reads). Interestingly,
one sequence from C. litteratus (Q2HZ30) deposited in the
UniProt-KB database and described as a “high frequency
protein” also contains the same signal peptide. The predicted
mature sequence of Mr096 displays a cysteine framework VIIII
(Supplemental Table S2) but includes an unusual repeat motif
(CRECK/R). Surprisingly, the predicted mature sequence of
Q2HZ30 had no cysteine residues and no sequence homol-
ogy to the mature Mr096. Although we could match the pre-
dicted mature sequence from Mr096 by MS within 100 ppm
with no PTMs, MS/MS data was inconclusive.
New Gene Superfamily H—Superfamily H has a signal pep-
tide that is divergent from previously known conopeptide
gene superfamilies ( 50% sequence identity). As a conse-
quence, the corresponding precursors were initially not recov-
ered in the homology search of the raw reads. Instead, pep-
tides belonging to this gene superfamily were first identified
through MS/MS data matching, illustrating the complementa-
rity of transcriptomic and proteomic data in conopeptide dis-
covery. From the seven precursors belonging to this gene
superfamily, six had six cysteines arranged in a classical VI/VII
cysteine framework (Supplemental Table S2), but Mr103 was
predicted to generate a different mature peptide. Mr097 and
Mr098 were the most highly expressed genes in this gene
superfamily (130 and 127 reads, respectively), whereas
Mr099, Mr100, and Mr103 were expressed at two- to fourfold
lower levels, and Mr101 and Mr102 only generated one and
four reads, respectively. Only the four short mature se-
quences from the precursors Mr097, Mr098, Mr099, and
Mr100 yielded good MS/MS data coverage. These precursors
contained an unconventional pre-cleavage site (RNWSR) and
their mature toxins have a hydroxyproline located in the first
inter-cysteine loop in all except Mr100.
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New Gene Superfamily E and F—The two precursors Mr104
and Mr105 had no significant homology to any known cono-
peptide sequences deposited in ConoServer. Mr104 had rel-
atively high expression (86 reads) whereas Mr105 gave only
two reads. No obvious cleavage site could be identified for the
Mr105 precursor, but a KRNGR pre-cleavage site was pre-
dicted for Mr104. MS/MS identified a propeptide of Mr105
(ELYDVNDPDVR) in the venom, however, Mr105 mature
peptide was not identified. The predicted mature sequence
of Mr104 was supported by MS/MS data, revealing a 26
amino acid peptide with two disulfide bonds and a
bromo-tryptophan.
A New Mechanism Expanding Conopeptide Diversity—The
high sensitivity of the TripleTOF 5600 System allowed us to
characterize on average 20 different peptide variants (i.e.
different precursor masses detected by mass spectrometry)
for each gene precursor (Fig. 7A). Unexpectedly, most of this
peptide diversity corresponded to truncated forms of either
the mature peptide, the propeptide, or sequences comprising
both the mature peptide and the propeptide. In addition to
these truncations, additional diversity was created by variable
PTM processing. The largest number of MS/MS sequences
identified was associated to the gene precursor of MrIA
(Mr090), with 72 unique peptide masses detected in the
venom of this highly expressed peptide. Based on the inten-
sity of the mass precursor ion, MrIA and its deamidated form
(21) dominated, with the next most intense mass precursor
ions ( 4% of deamidated MrIA) corresponding to the full
MrIA gene precursor propeptide (Fig. 7B and Table III). Other
mature MrIA-related peptides included N-terminal truncations
and PTMs including C-terminal amidation and sulfation of
tyrosine, not previously reported for gene superfamily T
peptides.
DISCUSSION
Using a combination of second-generation sequencing and
high-sensitivity mass spectrometry, we have unraveled the
venom molecular diversity of Conus marmoreus and identified
a new mechanism of variable peptide processing (VPP) that
contributes to the remarkable diversity of conopeptides. Se-
quences for 105 unique conopeptide precursors were re-
trieved from the transcriptome and classified into 13 gene
superfamilies. Conopeptides in gene superfamilies O1, T, M
dominated both in terms of their expression level and number
of isoforms, suggesting an important role in prey capture
and/or defense. Seven gene superfamilies not previously
known from C. marmoreus, including five novel gene super-
families, were also discovered. Our approach of integrating
transcriptomic and MS/MS sequence data allowed identifica-
tion of highly divergent gene superfamilies (e.g. superfamily H)
that were missed in simple homology searches. VPP, in com-
bination with intra-species variation within gene superfamilies,
can explain how  100 gene precursors generate thousands
of unique venom peptides in a single species of cone snail.
TABLE II
MS/MS coverage of transcriptomic sequences with a confidence
value of 99
Name Sequence
Mr001_Mr1.1 GCCSHPACSVNNPDIC
Mr002 RPECCTHPACHVSNPELCS
Mr003 DKWGTCSLLGKGCR
Mr005 HKWGACSLLGKD
Mr007_Mal51 QCEDVWMPCTSNWECCSLDCEMYCTQIG
Mr009 GCKATWMSCSSGWECCSMSCDMYC
Mr010 TAESWWEGECLGWSNGCTHPSDCCSNYCKGIYCDL
Mr011 SCDQTGEPCVLNEQCCYGWCTNHGTCY
Mr012 SCVPIGRPCASNEQCCTRWCTPRRIC
Mr013 DCLPIGSLCHSSEQCCSGWCSPKRVC
Mr014_Contryphan_M NESECPWHPWC
Mr015 ESECPWHPWC
Mr019_GlaMrll DQCMTWNRCLSAQTGN
Mr020 SQCTTWNRCLSAQTGN
Mr029_Mr3.3 ECCGSFACRFGCVPCCV
Mr030_MrIIIB SKQCCHLAACRFGCTPCCW
Mr033_MrIIIG DCCPLPACPFGCNPCC
Mr031 CCRIACNLKCNPCC
Mr032_MrIIID CCRLSCGLGCHPCC
Mr039 LCCWKEWCHARCTCC
Mr040 LCCWIHWCHARCTCC
Mr041 ICCPQGGCHQLCQCCGC
Mr049 VCCPHGGCHQICQCCGC
Mr042_MrIIIE VCCPFGGCHELCYCCD
Mr043_MrIIIF VCCPFGGCHELCLCCD
Mr047 VCCSFGSCDSLCQCCD
Mr050 VCCPFGECKSLCYCC
Mr044_Mr3.8 CCHWNWCDHLCSCCGS
Mr045 CCHRNWCDHLCSCCGS
Mr046_Mr1e CCHSSWCKHLC
Mr036_Conomarphin DWEYHAHPKPNSFWT
Mr037 DWVNHAHPQPNSIWS
Mr051_MrVIB ACSKKWEYCIVPILGFVYCCPGLICGPFVCV
Mr052 ACRQKWEYCIVPILGFVYCCPGLICGPFVCV
Mr053_MrVIA ACRKKWEYCIVPIIGFIYCCPGLICGPFVCV
Mr057_Malr34 ECLEADYYCVLPFVGNGMCCSGICVFVCIAQKY
Mr063_Malr332 CLDGGEICGILFPSCCSGWCIVLVCA
Mr064 CIDGGEICDIFFPNCCSGWCIILVCA
Mr065 CLDAGEMCDLFNSKCCSGWCIILVCA
Mr066_Mr6.1 CLDAGEMCDLFNSKCCSGWCIILFCA
Mr072 CIDGGEMCDPFSSDCCSGWCIFFFCT
Mr067_Mr6.3 CPNTGELCDVVEQNCCYTYCFIVVCL
Mr068_Malr137 DDECEPPGDFCGFFKIGPPCCSGWCFLWCA
Mr069 DDPRNGLENLFSKAHHEMKNPKDSKLN
Mr074_Mr5.4a CCQVMPQCCEWN
Mr075_Mr5.4b CCQIVPQCCEWN
Mr076 CCQIVPQCCEWVSD
Mr077_GlaMrIII FCCRTQEVCCEAIKNG
Mr082 LQMLRTNAAAQAGNCAASGMMGGKGK
Mr083 QMLRTNAAAQAGNCAASGMMGGKEND
Mr084_MrVA NACCIVRQCC
Mr085_Mr5.6 NGCCRAGDCCS
Mr087 TLQKLLNKTLLPN
Mr089 ACCVYKICYPC
Mr090_MrIA NGVCCGYKLCHPC
Mr091_CMrVIA NGVCCGYKLCHPC
Mr092_CMrX GICCGVSFCYPC
Mr093 CSSGKTCGSVEPVLCCARSDCYCRLIQT/SYWVPICVCP
Mr094 CRSGKTCPRVGPDVCCERSDCFCKLVPARPFWR
Mr095 ECCERSDCFCKMVPARPYWRNK
Mr097 STDCNGVPCQFGCCVTINGNDECRELDC
Mr098 STDCNGVPCEFGCCVTINGNDECREIGCE
Mr099 IEEDCGYVPCEFGCCRIIDGKEKCREIDCQ
Mr100 DDFMRIMCGDEFCTYDCCEIVDGSSKCKQPDCP
Mr104 LNCSLTCSCRRGESCLHGEYIDWDS
Mr105 ELYDVNDPDVR
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Table IV displays statistics on the gene superfamilies iden-
tified from 12 species of Conidae, including data from the
recently reported venom duct transcriptomes of C. consors
and C. pulicarius (17–19). Extensively studied mollusk-hunting
species including C. marmoreus (this study), have a compa-
rable distribution of transcripts across the different gene su-
perfamilies, with gene superfamilies M, O1, and T dominating.
In our study on C. marmoreus, this expression level translated
to a corresponding distribution of mature peptides in the
venom. Gene superfamilies M, O1, and T are also common in
vermivorous species (see Table IV). However, for the more
recently evolved piscivorous species C. consors and C. stria-
tus (54), gene superfamilies M and O1 are highly expressed,
along with gene superfamily A. Therefore, the requirement for
gene superfamily T in molluscivorous and vermivorous spe-
cies appears to have been lost in piscivorous species. C.
californicus is thought to be phylogenetically distinct from
other Conus species. Because only the gene superfamily O1
is shared as a large gene superfamily between C. californicus
and other Conidae, gene superfamily O1 may have evolved
early in the speciation of Conidae. The cysteine framework
VI/VII, the most common gene superfamily O1 conopeptides,
fold into a highly stable cysteine knot motif (55) found in a
wide range of bioactive peptides expressed across both the
animal and plant kingdoms. These cysteine knot peptides
have evolved in cone snails to selectively target voltage-gated
FIG. 7. Conotoxin diversity. A, Analy-
sis of the TripleTOF MS/MS data re-
vealed up to 72 peptides corresponding
to a single conotoxin encoded gene in
the venom of C. marmoreus. On aver-
age, 20 peptides per precursor were de-
tected. B, Mass distribution and relative
intensity of the 72 MrIA-related peptides.
The mature peptide (MrIA, and its
deamidated form) largely dominates in
the venom supporting the predicted
cleavage of selective endoproteases.
Other peptides (including MrIA and pro-
peptide truncations and PTMs variants)
were present at less than 5% of MrIA (or
less than 1% for  90% of the peptides,
as represented by the dotted line).
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TABLE III
Conopeptide diversity: example of MrIA (Triple TOF data)
Intensity
precursor
Relative
intensity
Precursor
MW (Da) Conf Sequence
a Modifications dMass(Da)
9694 0.13 4535.26  1 VVVLPKTEDDVPMSSVYGNGKSILRGILRNGVCCGYKLCHPC Oxidation(P)@41 0.0008
6240 0.08 4536.26  1 VVVLPKTEDDVPMSSVYGNGKSILRGILRNGVCCGYKLCHPC Deamidated(N)@30;
Oxidation(P)@41
0.0176
1540 0.02 2985.63 96.34 VVVLPKTEDDVPMSSVYGNGKSILRGIL 0.0053
1267 0.02 2986.60 15.9 VVVLPKTEDDVPMSSVYGNGKSILRGIL Deamidated(N)@19 0.0007
25259 0.34 2703.43 99 VVVLPKTEDDVPMSSVYGNGKSILR Deamidated(N)@19 0.0153
20398 0.28 2702.44 99 VVVLPKTEDDVPMSSVYGNGKSILR 0.0108
288699 3.90 2547.52 99 VVVLPKTEDDVPMSSVYGNGKSIL Deamidated(N)@19 0.2078
35465 0.48 2546.32 99 VVVLPKTEDDVPMSSVYGNGKSIL 0.0075
4131 0.06 2433.25 19.5 VVVLPKTEDDVPMSSVYGNGKSI 0.0074
2979 0.04 2434.24 46.5 VVVLPKTEDDVPMSSVYGNGKSI Deamidated(N)@19 0.0120
2590 0.04 2320.17 99 VVVLPKTEDDVPMSSVYGNGKS 0.0070
1648 0.02 2321.16  1 VVVLPKTEDDVPMSSVYGNGKS Deamidated(N)@19 0.0120
1996 0.03 2234.13 60.28 VVVLPKTEDDVPMSSVYGNGK Deamidated(N)@19 0.0132
2854 0.04 2105.03 99 VVVLPKTEDDVPMSSVYGNG 0.0035
8022 0.11 1876.95 91.92 VVVLPKTEDDVPMSSVY 0.0001
10443 0.14 1614.82 98.9 VVVLPKTEDDVPMSS 0.0020
20565 0.28 1527.79 99 VVVLPKTEDDVPMS 0.0024
214305 2.90 1440.85 99 VVVLPKTEDDVPM 0.0938
4143 0.06 1456.75  1 VVVLPKTEDDVPM Oxidation(M)@13 0.0001
2232 0.03 1309.72 67.7 VVVLPKTEDDVP 0.0068
2321 0.03 998.56 13.6 VVVLPKTED 0.0009
807 0.01 653.42 39.9 VVVLPK 0.0320
7395262 100.00 1412.54 99 NGVCCGYKLCHPC Deamidated(N)@1;
Oxidation(P)@12
0.0012
3680413 49.77 1411.55 99 NGVCCGYKLCHPC Oxidation(P)@12 0.0024
53999 0.73 1396.54 99 NGVCCGYKLCHPC Deamidated(N)@1 0.0001
37458 0.51 1395.54 99 NGVCCGYKLCHPC 0.0128
28619 0.39 1394.53 99 NGVCCGYKLCHPC Amidated@C-term 0.0422
6960 0.09 1309.53 72.2 NGVCCGYKLCHP Deamidated(N)@1;
Oxidation(P)@12
0.0007
3680 0.05 1293.53 40.2 NGVCCGYKLCHP Deamidated(N)@1 0.0006
586 0.01 1371.59  1 NGVCCGYKLCHP Sulfo(Y)@7;
Amidated@C-term
0.0748
24899 0.34 1059.42 99 NGVCCGYKLC Deamidated(N)@1 0.0011
8593 0.12 1058.44 99 NGVCCGYKLC 0.0053
2577 0.03 956.41 99 NGVCCGYKL Deamidated(N)@1 0.0009
821 0.01 955.38 43.5 NGVCCGYKL Deamidated(N)@1;
Amidated@C-term
0.0445
1707 0.02 842.34 99 NGVCCGYK 0.0003
23473 0.32 3899.82 19.6 TEDDVPMSSVYGNGKSILRGILRNGVCCGYKLCHPC Oxidation(M)@7 0.0078
15030 0.20 3900.81 52.7 TEDDVPMSSVYGNGKSILRGILRNGVCCGYKLCHPC Deamidated(N)@24;
Oxidation(P)@35
0.0012
28026 0.38 2066.92 99 TEDDVPMSSVYGNGKSILR 0.0780
2458 0.03 2067.99 8.2 TEDDVPMSSVYGNGKSILR Deamidated(N)@13 0.0075
178230 2.41 1910.89 99 TEDDVPMSSVYGNGKSIL 0.0049
21181 0.29 1911.88 99 TEDDVPMSSVYGNGKSIL Deamidated(N)@13 0.0012
3141 0.04 1684.72 99 TEDDVPMSSVYGNGKS 0.0052
7636 0.10 1469.60 63.07 TEDDVPMSSVYGNG 0.0010
1397 0.02 1491.58 13.2 TEDDVPMSSVYGN Sulfo(Y)@11;
Amidated@C-term
0.0310
1752 0.02 1314.77  1 ILRGILRNGVCC Amidated@C-term 0.0316
228 0.00 956.60 95.9 NGKSILRGI 0.0271
91329 1.23 1850.84 99 GILRNGVCCGYKLCHPC Oxidation(P)@19 0.0016
24507 0.33 1834.85  1 GILRNGVCCGYKLCHPC 0.0032
16702 0.23 1851.83 99 GILRNGVCCGYKLCHPC Deamidated(N)@5;
Oxidation(P)@19
0.0056
67418 0.91 1810.79  1 GILRNGVCCGYKLCHP Sulfo(Y)@11;
Amidated@C-term
0.0192
10658 0.14 1680.74 65.5 LRNGVCCGYKLCHPC Oxidation(P)@14 0.0005
17441 0.24 1294.52  1 RNGVCCGYKLC Sulfo(Y)@8 0.0295
65392 0.88 1240.48 99 VCCGYKLCHPC Oxidation(P)@10 0.0026
1134 0.02 1205.34  1 CCGYKLCHPC Sulfo(Y)@4 0.0358
15421 0.21 1038.41 99 CGYKLCHPC Oxidation(P)@8 0.0001
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sodium, potassium, or calcium channels (11), explaining why
conotoxins from gene superfamily O1 appear to be central to
the success of Conidae. For example MrVIA and MrVIB from
the gene superfamily O1 inhibit the calcium channels in mol-
luscs indicating a direct role in prey capture (48, 49), as well as
selectively inhibiting the mammalian neuronal voltage-gated
sodium channel Nav1.8 to produce intrathecal analgaesia (56,
57). In contrast, the biological activity for a number of other C.
marmoreus conopeptides has only been demonstrated at
mammalian targets. For instance, intracranial injections in
mice identified that Mr1e was excitatory, CMrX was paralytic,
and CMrVIA produced seizures (45, 51). Further, contryphan
blocks L-type calcium channels in mouse pancreatic B-cells
(58), Mr1.1 inhibits rodent nicotinic acetylcholine receptors
(36, 58) and MrIA non-competitively inhibits the human nora-
drenaline transporter (53). This remarkable diversity of biolog-
ical actions indicates that C. marmoreus uses multiple target
strategy to broadly disrupt neuronal function of prey and/or
predators.
This study has shown that the level of precursor transcrip-
tion, as estimated by the number of reads for each transcript,
reflects the levels of the corresponding conopeptides found in
the crude venom. For example, transcript Mr044 was the
most highly expressed transcript in C. marmoreus venom
duct and its corresponding conopeptide Mr3.8 was also one
of the most prominent ions detected in the injected venom
(Fig. 6). In contrast, precursors expressed at low levels could
rarely be confirmed by MS/MS analysis. While evolutionary
pressures are expected to influence the level of expressed
conopeptides (59, 60), it remains to be determined whether
conopeptides expressed at low levels are recently evolved or
in the process of being deselected.
We observed a significant disparity between the number of
conopeptide genes and the number of masses detected by
mass spectrometry, confirming previous studies (15, 16).
Compared with the 105 conopeptide precursors identified in
the venom gland transcriptome, 7798 unique masses were
identified using the combined results from three MS platforms
TABLE III—continued
Intensity
precursor
Relative
intensity
Precursor
MW (Da) Conf Sequence
a Modifications dMass(Da)
33291 0.45 999.27  1 GYKLCHPC Sulfo(Y)@2 0.0932
2659 0.04 935.40 39.9 GYKLCHPC Oxidation(P)@7 0.0003
1195 0.02 878.38 9.4 YKLCHPC Oxidation(P)@6 0.0020
190945 2.58 1297.52 99 GVCCGYKLCHPC Oxidation(P)@11 0.0141
7964 0.11 1377.49 86.5 GVCCGYKLCHPC Sulfo(Y)@6;
Oxidation(P)@11
0.0298
1106 0.01 1281.51  1 GVCCGYKLCHPC 0.0035
1940 0.03 2320.17 12.56 PMSSVYGNGKSILRGILRNGVC 0.0482
1144 0.02 2292.17  1 PKTEDDVPMSSVYGNGKSILR 0.0279
1472 0.02 1821.79  1 PKTEDDVPMSSVYGNGK Amidated@C-term 0.0656
4293 0.06 1694.75 21 PKTEDDVPMSSVYGNG 0.0043
2526 0.03 1717.62  1 PKTEDDVPMSSVYGN Sulfo(Y)@13 0.0619
4231 0.06 1809.82 29.3 EDDVPMSSVYGNGKSIL 0.0225
3515 0.05 1836.91  1 DDVPMSSVYGNGKSILR 0.0023
1243 0.02 1567.72 97.8 DDVPMSSVYGNGKSI 0.0050
833 0.01 1454.64 97.9 DDVPMSSVYGNGKS 0.0011
10443 0.14 1614.82 98.9 VVLPKTEDDVPMSSV 0.0020
63416 0.86 1036.69  1 PGVVVLPKTE Amidated@C-term 0.0594
aBold indicates peptide ion precursors with a relative intensity more than 1% of the deamidated MrIA.
TABLE IV
Conotoxin transcript and gene superfamily statistics extracted from ConoServer database
Species No. transcripts No. mature Clades Diet A I1 I2 M O1 O2 T Others
C. marmoreus 105 (this study) 66 VI M 2 3 10 22 20 10 18 16
C. textile 105 87 V M 6 2 32 29 12 13 6
C. pennaceus 43 39 V M 13 25 19 32 11
C. ventricosus 47 38 V 9 28 7 33 23
C. pulicarius 82 V 12a 5 50b 6 27
C. literatus 74 63 V 7 8 18 11 5 22 29
C. lividus 50 34 VII V 38 48 4 6 4
C. ebraeus 48 40 XI V 54 46
C. arenatus 40 37 XIV V 2 2 5 20 47 12 12
C. striatus 80 59 I P 11 1 26 45 1 1 15
C. consors 61 I P 23 13 25b 8 31
C. californicus 98 125 Early P 3 1 22 5 69
aSum of I1 and I2.
bSum of O1 and O2.
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with stringent de-replication. To understand the mechanisms
responsible for this 75-fold disparity, reduced and alkylated
venom was analyzed in detail by MS/MS. Using this ap-
proach, 1385 peptide fragments sequenced by MS/MS could
be matched to  60% of the 105 precursors, providing the
most comprehensive study to-date on animal venom com-
plexity. Surprisingly, the majority of identified conopeptides
were differentially processed N- and C-terminal variants. For
each gene precursor, one or two conopeptides typically
dominated quantitatively ( 95%) and these invariably cor-
responded to conopeptides cleaved at a predicted R/K
cleavage site. The remaining variants arise from enzyme
processing at alternative R/K cleavage sites in the sequence,
or they appear to arise from enzymes with low substrate
specificity or an alternative substrate preference. Because
these alternatively cleaved forms are always less abundant
than the full length mature peptide, their biological relevance
is unclear. However, because conopeptides differing by only
a few residues at their N- or C termini can have altered
biological activity (61–63), this VPP is expected to have evo-
lutionary significance. Together with the hypermutations seen
at the mRNA level, VPP is a new mechanism that contributes
to “biological messiness” in venoms, a concept recently de-
veloped in the field of enzymology to explain the origins of
evolutionary innovation (64).
This study has also demonstrated that propeptide se-
quences can survive intact in cone snail venom. In C. mar-
moreus these were identified from gene superfamily I1, M, O1,
O2, and T precursors, and again were subject to variable
cleavage that expanded their diversity. While still attached to
the mature peptide, the proregion is known to facilitate the ER
export of hydrophobic mature conotoxins (65), however, no
role has yet been assigned to the propeptide itself. It will be
interesting to identify if these mostly linear peptides have
biological activity and to what extent they contribute to the
envenomation process and conopeptide evolution.
CONCLUSIONS
Our analysis of the more than 7500 conopeptides used by
C. marmoreus for prey capture and defense represents the
most exhaustive transcriptomic/proteomic study of cone snail
venom to date. In addition to accelerating the rate of dis-
covery of novel venom peptides (75 novel conopeptide
precursors), the combined strategy using second generation
sequencing technologies and high sensitivity mass spectrom-
etry has allowed the identification of a novel mechanism of
variable peptide processing (VPP). VPP produces diverse N-
and C-terminal truncations that exponentially increase the
number of peptides generated from a limited number of
genes. On average 20 conopeptides (1–72) were generated
from each precursor sequence. When applied to each of the
105 conopeptide precursors, an estimated 2000 conopep-
tides are predicted to be generated by a single C. marmoreus
specimen. Significant intraspecific venom variability (16) likely
explains the additional conopeptides observed in the pooled
milked venom obtained from six C. marmoreus (7798 pep-
tides detected using the three MS platforms). Thus, VPP in
combination with intraspecific variability explains for the first
time how cone snail can produce exquisitely complex venoms
from relatively limited gene sets. VPP may represent a more
general phenomena accounting for highly diverse venoms
( 1000 peptides) observed in other animals, including spider
venoms (66), contributing to the “biological messiness” in
venoms and associated rapid and adaptive evolution of toxins
for prey capture and defense. The next challenge in venomics
will involve coupling this accelerated discovery strategy to
high throughput synthesis and bioassays (67, 68) to acceler-
ate molecular target identification and selectivity profiling of
new conotoxins.
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